Table B2. Congressional Budget Justification Sexually Transmitted Diseases Goals, Measures, and Target

This is a table caption for compliance. Please ignore it.
Congressional Budget Justification Goals Actual Target
2016 2017 2018 2020
Contextual Indicators 2.7.6e. Proportion of sexually active females aged 16–24 years enrolled in Medicaid who are screened for chlamydia infections 60.0% 60.7%* N/A 60.0%
2.7.6f. Proportion of sexually active females aged 16–24 years enrolled in commercial health insurance plans who are screened for chlamydia infections 50.1% 51.5%* N/A 50.1%
2.7.7. Reduce the rate† of symptomatic gonorrhea cases in men 146.1 148.3 173.4 148.3
Performance Measures for Long Term Objective: Reduce Pelvic Inflammatory Disease in the U.S. 2.7.5. Increase the proportion of gonorrhea patients who are treated with a CDC-recommended antibiotic regimen for gonorrhea 81.3% 82.4% 85.8% 87.6%
2.9.1. Reduce the incidence of P&S syphilis/100,000 population in women aged 15–44 4.2 5.1 6.9 0.8
2.9.2. Reduce the incidence of congenital syphilis/100,000 live births 15.7 23.3 33.1 6.2
2.9.3. Increase the percentage of pregnant women that are screened for syphilis at least one month before delivery 89.5% 89.9% N/A 87.2%
2.9.4. Increase the proportion of potential congenital syphilis cases averted 75.0% 72.0% N/A 75.0%
2.9.5. Reduce the rate of increase of P&S syphilis 18.0% 11.0% 15.0% 9.0%

 

This is a table caption for compliance. Please ignore it.
Goals Data Source
2.7.6e, 2.7.6f Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA)
2.7.5, 2.7.7 STD Surveillance Network (SSuN), CDC
2.9.1, 2.9.2, 2.9.4, 2.9.5 National Notifiable Disease Surveillance System (NNDSS), CDC
2.9.3 MarketScan Commercial Claims and Encounters Database, Truven Health Analytics

P&S = primary and secondary.
* Proportion based on average screening coverage across plans, weighted by the number of sexually-active women in each plan.
† Per 100,000.